Olutasidenib
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Olutasidenib, covering 2025-02-21 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy [Phase 2]